Interview Intersection: Expert Interviews From February 2025

Omar Noor, MD, FAAD, discussed the buy-and-bill process for biologic treatments in dermatology, emphasizing its efficiency and financial predictability. He outlined a streamlined workflow, from treatment selection and insurance coordination to rapid medication delivery and reimbursement. Despite its success in other medical fields, buy-and-bill remains underutilized in dermatology. Noor highlighted its benefits for patient care and practice management, particularly for biologics like tildrakizumab, and encouraged clinicians to adopt and customize the model.